Olli Kampman

3.3k total citations
112 papers, 2.1k citations indexed

About

Olli Kampman is a scholar working on Psychiatry and Mental health, Clinical Psychology and Pharmacology. According to data from OpenAlex, Olli Kampman has authored 112 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 56 papers in Psychiatry and Mental health, 25 papers in Clinical Psychology and 19 papers in Pharmacology. Recurrent topics in Olli Kampman's work include Schizophrenia research and treatment (34 papers), Bipolar Disorder and Treatment (24 papers) and Treatment of Major Depression (18 papers). Olli Kampman is often cited by papers focused on Schizophrenia research and treatment (34 papers), Bipolar Disorder and Treatment (24 papers) and Treatment of Major Depression (18 papers). Olli Kampman collaborates with scholars based in Finland, Sweden and United States. Olli Kampman's co-authors include Esa Leìnonen, Terho Lehtimäki, Ari Illi, Merja Viikki, Outi Poutanen, Sami Anttila, K. Lehtinen, Kari M. Mattila, Nina Mononen and Eija Setälä-Soikkeli and has published in prestigious journals such as American Journal of Psychiatry, Journal of Affective Disorders and BMC Public Health.

In The Last Decade

Olli Kampman

104 papers receiving 2.1k citations

Peers

Countries citing papers authored by Olli Kampman

Since Specialization

Citations

This map shows the geographic impact of Olli Kampman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Olli Kampman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Olli Kampman more than expected).

Fields of papers citing papers by Olli Kampman

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Olli Kampman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Olli Kampman. The network helps show where Olli Kampman may publish in the future.

Co-authorship network of co-authors of Olli Kampman

This figure shows the co-authorship network connecting the top 25 collaborators of Olli Kampman. A scholar is included among the top collaborators of Olli Kampman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Olli Kampman. Olli Kampman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Leptin and leptin receptor gene polymorphisms and depression treatment response 2024 ·Acta Neuropsychiatrica ·(unknown), Anssi Solismaa, Leo-Pekka Lyytikäinen, Nina Mononen, Eeva Moilanen, Mari Hämäläinen, Terho Lehtimäki, Olli Kampman	0
2	Geographical variation in treated psychotic and other mental disorders in Finland by region and urbanicity 2023 ·Social Psychiatry and Psychiatric Epidemiology ·(unknown), (unknown), Jaakko Nevalainen, Jaana Suvisaari, Christian Hakulinen, Olli Kampman, Sami Pirkola	5
3	Machine Learning Classification of Psychiatric Data Associated with Compensation Claims for Patient Injuries 2023 ·Methods of Information in Medicine ·Martti Juhola, (unknown), (unknown), (unknown), Olli Kampman	0
4	Substance Use and Sleep Problems in Patients With Psychotic Disorders 2022 ·Schizophrenia Bulletin Open ·(unknown), Minna Torniainen‐Holm, (unknown), Markku Lähteenvuo, Jarmo Hietala, (unknown), Erkki Isometsä, Olli Kampman, (unknown), Jouko Lönnqvist, Jaana Suvisaari, Jari Tiihonen, (unknown), Juha Veijola, Aarno Palotie, Tuula Kieseppä, Solja Niemelä, Tiina Paunio	1
5	Differences in psychosocial functioning between psychotic disorders in the Finnish SUPER study 2022 ·Schizophrenia Research ·(unknown), Tuula Kieseppä, Jaana Suvisaari, (unknown), Minna Torniainen‐Holm, (unknown), Ari Ahola‐Olli, (unknown), Olli Kampman, Markku Lähteenvuo, Tiina Paunio, Jari Tiihonen, Annamari Tuulio‐Henriksson, Erkki Isometsä	2
6	Electroconvulsive therapy increases temporarily plasma vascular endothelial growth factor in patients with major depressive disorder 2021 ·Brain and Behavior ·(unknown), Kaija Järventausta, Olli Kampman, Kai Lehtimäki, (unknown), (unknown), Mari Hämäläinen, Eeva Moilanen, Esa Leìnonen	8
7	Glucagon-like peptide-1 serum levels are associated with weight gain in patients treated with clozapine 2021 ·Psychiatry Research ·(unknown), Anssi Solismaa, Niko Seppälä, Mari Hämäläinen, Eeva Moilanen, Esa Leìnonen, Olli Kampman	4
8	Effect of electroconvulsive therapy on brain‐derived neurotrophic factor levels in patients with major depressive disorder 2018 ·Brain and Behavior ·(unknown), Kaija Järventausta, Olli Kampman, Kai Lehtimäki, (unknown), (unknown), Mari Hämäläinen, Eeva Moilanen, Esa Leìnonen	17
9	Temperament and character profiles are associated with depression outcome in psychiatric secondary care patients with harmful drinking 2018 ·Comprehensive Psychiatry ·(unknown), (unknown), (unknown), Esa Leìnonen, Olli Kampman	2
10	Behavioral activation versus treatment as usual in naturalistic sample of psychiatric patients with depressive symptoms: a benchmark controlled trial 2018 ·BMC Psychiatry ·(unknown), (unknown), (unknown), (unknown), (unknown), Esa Leìnonen, Olli Kampman	8
11	Outcome of patients with dual diagnosis in secondary psychiatric care 2016 ·Nordic Journal of Psychiatry ·(unknown), (unknown), (unknown), Olli Kampman	9
12	Polymorphism in alpha 2A adrenergic receptor gene is associated with sialorrhea in schizophrenia patients on clozapine treatment 2014 ·Human Psychopharmacology Clinical and Experimental ·Anssi Solismaa, Olli Kampman, Niko Seppälä, Merja Viikki, Kari-Matti Mäkelä, Nina Mononen, Terho Lehtimäki, Esa Leìnonen	16
13	Association Study of the HTR2C, Leptin and Adiponectin Genes and Serum Marker Analyses in Clozapine Treated Long-Term Patients with Schizophrenia 2014 ·European Psychiatry ·(unknown), Olli Kampman, Niko Seppälä, Merja Viikki, Mari Hämäläinen, Eeva Moilanen, Nina Mononen, Terho Lehtimäki, Esa Leìnonen	29
14	No support for a role for BDNF gene polymorphisms rs11030101 and rs61888800 in major depressive disorder or antidepressant response in patients of Finnish origin 2012 ·Psychiatric Genetics ·Ari Illi, Merja Viikki, Outi Poutanen, Eija Setälä-Soikkeli, (unknown), Olli Kampman, Esa Leìnonen, Heini Huhtala, Nina Mononen, Terho Lehtimäki	14
15	One-Year Follow-Up After Discontinuing Maintenance Electroconvulsive Therapy 2012 ·Journal of Ect ·Kaija Huuhka, Merja Viikki, Tarja Tammentie, (unknown), (unknown), (unknown), Esa Leìnonen, Olli Kampman	25
16	Can onset and recovery in depression be predicted by temperament? A systematic review and meta-analysis 2011 ·Journal of Affective Disorders ·Olli Kampman, Outi Poutanen	116
17	Vascular endothelial growth factor (VEGF) polymorphism is associated with treatment resistant depression 2010 ·Neuroscience Letters ·Merja Viikki, Sami Anttila, Olli Kampman, Ari Illi, Martti Huuhka, Eija Setälä-Soikkeli, Nina Mononen, Terho Lehtimäki, Esa Leìnonen	62
18	5-HTR1A, 5-HTR2A, 5-HTR6, TPH1 and TPH2 polymorphisms and major depression 2009 ·Neuroreport ·Ari Illi, Eija Setälä-Soikkeli, Merja Viikki, Outi Poutanen, Heini Huhtala, Nina Mononen, Terho Lehtimäki, Esa Leìnonen, Olli Kampman	98
19	RGS4 genotype is not associated with antipsychotic medication response in schizophrenia 2006 ·Journal of Neural Transmission ·Olli Kampman, Ari Illi, (unknown), Heikki Katila, (unknown), Riikka Rontu, Kari M. Mattila, Esa Leìnonen, Terho Lehtimäki	15
20	The reliability of compliance assessments performed by doctors and patients during neuroleptic treatment: a comparison of compliance ratings 2001 ·Acta Psychiatrica Scandinavica ·Olli Kampman, Klaus Lehtinen, (unknown)	3

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact